Statutory Instruments

MISUSE OF DRUGS (DESIGNATION) (AMENDMENT) ORDER 2017 S.I. No. 533 of 2017

The purpose of this Order is to amend the Misuse of Drugs (Designation)
Order 2017 by inserting into Schedule 1 to that Order the following:
3,4-Dichloro-N-(2-dimethylamino-cyclohexyl)-N-methyl-benzamide
(otherwise known as U-47700);
Ethyl phenyl(piperidin-2-yl)acetate (otherwise known as Ethylphenidate);
[1-(5-Fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
(otherwise known as XLR-11); and
N-Methyl-1-(thiophen-2-yl)propan-2-amine (otherwise known as
Methiopropamine).
This Order may be cited as the Misuse of Drugs (Designation) (Amendment)
Order 2017.

S.I. No. 533 of 2017